{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:30:03Z","timestamp":1772119803859,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004850","name":"Gaziosmanpasa \u00dcniversitesi","doi-asserted-by":"publisher","award":["2015\/67"],"award-info":[{"award-number":["2015\/67"]}],"id":[{"id":"10.13039\/501100004850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s11033-023-08830-6","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T13:01:52Z","timestamp":1696942912000},"page":"9335-9341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Could NCOA5 a novel candidate gene for multiple sclerosis susceptibility?"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3143-5475","authenticated-orcid":false,"given":"Husniye","family":"Rustemoglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4992-5915","authenticated-orcid":false,"given":"Erdem","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sema","family":"Atasever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1285-6589","authenticated-orcid":false,"given":"Betul","family":"Cevik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3780-4021","authenticated-orcid":false,"given":"Filiz","family":"Taspinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5972-0147","authenticated-orcid":false,"given":"Ahmet B\u00fclent","family":"Turhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1354-4598","authenticated-orcid":false,"given":"Aydin","family":"Rustemoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,10]]},"reference":[{"issue":"7","key":"8830_CR1","doi-asserted-by":"publisher","first-page":"a028951","DOI":"10.1101\/cshperspect.a028951","volume":"8","author":"NA Patsopoulos","year":"2018","unstructured":"Patsopoulos NA (2018) Genetics of multiple sclerosis: an overview and new directions. Cold Spring Harb Perspect Med 8(7):a028951. https:\/\/doi.org\/10.1101\/cshperspect.a028951","journal-title":"Cold Spring Harb Perspect Med"},{"key":"8830_CR2","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.3389\/fimmu.2017.01810","volume":"21","author":"DAE Hendrickx","year":"2017","unstructured":"Hendrickx DAE, van Scheppingen J, van der Poel M, Bossers K, Schuurman KG, van Eden CG, Hol EM, Hamann J, Huitinga I (2017) Gene expression profiling of multiple sclerosis pathology identifies early patterns of demyelination surrounding chronic active lesions. Front Immunol 21:1810\u20131825. https:\/\/doi.org\/10.3389\/fimmu.2017.01810","journal-title":"Front Immunol"},{"issue":"1\u20132","key":"8830_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jneuroim.2003.08.023","volume":"143","author":"M Santos","year":"2003","unstructured":"Santos M, Pinto-Basto J, Rio ME, S\u00e1 MJ, Valen\u00e7a A, S\u00e1 A, Dinis J, Figueiredo J, Bigotte de Almeida L, Coelho I, Sawcer S, Setakis E, Compston A, Sequeiros J, Maciel P (2003) Whole genome screen for association with multiple sclerosis in portuguese patients. J Neuroimmunol 143(1\u20132):112\u2013115. https:\/\/doi.org\/10.1016\/j.jneuroim.2003.08.023","journal-title":"J Neuroimmunol"},{"issue":"3","key":"8830_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.autrev.2011.05.007","volume":"11","author":"AD Sadovnick","year":"2012","unstructured":"Sadovnick AD (2012) Genetic background of multiple sclerosis. Autoimmun Rev 11(3):163\u2013166. https:\/\/doi.org\/10.1016\/j.autrev.2011.05.007","journal-title":"Autoimmun Rev"},{"issue":"9","key":"8830_CR5","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S1474-4422(22)00255-1","volume":"21","author":"A Goris","year":"2022","unstructured":"Goris A, Vandebergh M, McCauley JL, Saarela J, Cotsapas C (2022) Genetics of multiple sclerosis: lessons from polygenicity. Lancet Neurol 21(9):830\u2013842. https:\/\/doi.org\/10.1016\/S1474-4422(22)00255-1","journal-title":"Lancet Neurol"},{"key":"8830_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1399-0039.1972.tb00060.x","volume":"2","author":"J Bertrams","year":"1972","unstructured":"Bertrams J, Kuwert E, Liedtke U (1972) HL-A antigens and multiple sclerosis. Tissue Antigens 2:405\u2013408","journal-title":"Tissue Antigens"},{"key":"8830_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13059-017-1207-1","volume":"18","author":"V Matzaraki","year":"2017","unstructured":"Matzaraki V, Kumar V, Wijmenga C, Zhernakova A (2017) The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol 18:76. https:\/\/doi.org\/10.1186\/s13059-017-1207-1","journal-title":"Genome Biol"},{"key":"8830_CR8","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1093\/hmg\/ddl22","volume":"15","author":"LF Barcellos","year":"2006","unstructured":"Barcellos LF, Sawcer S, Ramsay PP et al (2006) Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 15:2813\u20132824. https:\/\/doi.org\/10.1093\/hmg\/ddl22","journal-title":"Hum Mol Genet"},{"issue":"6","key":"8830_CR9","doi-asserted-by":"publisher","first-page":"1008180","DOI":"10.1371\/journal.pgen.1008737","volume":"15","author":"C Vilari\u00f1o-G\u00fcell","year":"2019","unstructured":"Vilari\u00f1o-G\u00fcell C, Zimprich A, Martinelli-Boneschi F, Herculano B, Wang Z et al (2019) Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease. PLoS Genet 15(6):1008180\u20131008220. https:\/\/doi.org\/10.1371\/journal.pgen.1008737","journal-title":"PLoS Genet"},{"issue":"6","key":"8830_CR10","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/ana.22609","volume":"70","author":"NA Patsopoulos","year":"2011","unstructured":"Patsopoulos NA, Bayer Pharma MS, Genetics Working Group, Esposito F et al (2011) Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 70(6):897\u2013912. https:\/\/doi.org\/10.1002\/ana.22609","journal-title":"Ann Neurol"},{"issue":"26","key":"8830_CR11","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1056\/NEJMoa0807917","volume":"359","author":"DJ Smyth","year":"2008","unstructured":"Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, Howson JM, Stevens H, McManus R, Wijmenga C, Heap GA, Dubois PC, Clayton DG, Hunt KA, van Heel DA, Todd JA (2008) Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 359(26):2767\u20132777. https:\/\/doi.org\/10.1056\/NEJMoa0807917","journal-title":"N Engl J Med"},{"key":"8830_CR12","doi-asserted-by":"publisher","first-page":"eaav7188","DOI":"10.1126\/science.aav7188","volume":"365","author":"International Multiple Sclerosis Genetics Consortium","year":"2019","unstructured":"International Multiple Sclerosis Genetics Consortium (2019) Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 365:eaav7188. https:\/\/doi.org\/10.1126\/science.aav7188","journal-title":"Science"},{"issue":"12","key":"8830_CR13","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/ng.2467","volume":"44","author":"LC Tsoi","year":"2012","unstructured":"Tsoi LC, Spain SL, Knight J, Ellinghaus E, Stuart PE et al (2012) Identifcation of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 44(12):1341\u20131348. https:\/\/doi.org\/10.1038\/ng.2467","journal-title":"Nat Genet"},{"key":"8830_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1089\/gtmb.2013.0387","volume":"18","author":"S Hu","year":"2014","unstructured":"Hu S, Chen Y, Sun XD, Li FJ, Shu QF, Liu XL et al (2014) Association between IL-6-174G\/C polymorphism and risk of multiple sclerosis: a meta-analysis. Genet Test Mol Biomark 18:127\u2013130. https:\/\/doi.org\/10.1089\/gtmb.2013.0387","journal-title":"Genet Test Mol Biomark"},{"key":"8830_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0304-3940(00)01543-3","volume":"294","author":"LM Sch\u00f6nrock","year":"2000","unstructured":"Sch\u00f6nrock LM, Gawlowski G, Br\u00fcck W (2000) Interleukin-6 expression in human multiple sclerosis lesions. Neurosci Lett 294:45\u201348. https:\/\/doi.org\/10.1016\/S0304-3940(00)01543-3","journal-title":"Neurosci Lett"},{"key":"8830_CR16","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.neuron.2016.04.039","volume":"1","author":"Z Wang","year":"2016","unstructured":"Wang Z, Sadovnick AD, Traboulsee AL, Ross JP, Bernales CQ, Encarnacion M et al (2016) Nuclear receptor NR1H3 in familial multiple sclerosis. Neuron 1:948\u2013954. https:\/\/doi.org\/10.1016\/j.neuron.2016.04.039","journal-title":"Neuron"},{"key":"8830_CR17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.humimm.2011.05.014","volume":"72","author":"MI Zervou","year":"2011","unstructured":"Zervou MI, Goulielmos GN, Castro-Giner F, Boumpas DT, Tosca AD, Krueger-Krasagakis S (2011) A CD40 and an NCOA5 gene polymorphism confer susceptibility to psoriasis in a southern european population: a case\u2013control study. Hum Immunol 72:761\u2013765. https:\/\/doi.org\/10.1016\/j.humimm.2011.05.014","journal-title":"Hum Immunol"},{"key":"8830_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jns.2016.08.045","volume":"15","author":"MM Eftekharian","year":"2016","unstructured":"Eftekharian MM, Noroozi R, Sayad A, Sarrafzadeh S, Toghi M, Azimi T et al (2016) RAR-related orphan receptor A (RORA): a new susceptibility gene for multiple sclerosis. Neurol Sci 15:259\u2013262. https:\/\/doi.org\/10.1016\/j.jns.2016.08.045","journal-title":"Neurol Sci"},{"key":"8830_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.17179\/excli2017-189","volume":"16","author":"A Rustemoglu","year":"2017","unstructured":"Rustemoglu A, Inal EE, Inanir A, Ekinci D, Gul U, Yigit S et al (2017) Clinical significance of NCOA5 gene rs2903908 polymorphism in Beh\u00e7et\u2019s disease. EXCLI j 16:609\u2013617. https:\/\/doi.org\/10.17179\/excli2017-189","journal-title":"EXCLI j"},{"key":"8830_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-52105-9","volume":"9","author":"S Gao","year":"2019","unstructured":"Gao S, Zhang Y, Yang C, Perez GI, Xiao H (2019) NCOA5 haplo-insufficiency results in male mouse infertility through increased IL-6 expression in the epididymis. Sci Rep 9:1\u201311. https:\/\/doi.org\/10.1038\/s41598-019-52105-9","journal-title":"Sci Rep"},{"key":"8830_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1148\/radiology.195.3.7754002","volume":"31","author":"W Sheremata","year":"2013","unstructured":"Sheremata W, Tornes L (2013) Multiple sclerosis and the spinal cord. Neurol Clin 31:55\u201377. https:\/\/doi.org\/10.1148\/radiology.195.3.7754002","journal-title":"Neurol Clin"},{"issue":"6","key":"8830_CR22","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1016\/j.annrmp.2007.04.004","volume":"50","author":"P Gallien","year":"2007","unstructured":"Gallien P, Nicolas B, Robineau S, P\u00e9trilli S, Houedakor J, Durufle A (2007) Physical training and multiple sclerosis. Ann Phys Rehabil Med 50(6):e373\u2013e376. https:\/\/doi.org\/10.1016\/j.annrmp.2007.04.004","journal-title":"Ann Phys Rehabil Med"},{"key":"8830_CR23","first-page":"75","volume":"28","author":"Z Akp\u0131nar","year":"2011","unstructured":"Akp\u0131nar Z, G\u00fcnd\u00fcz ZB (2011) Multipl Skleroz ve Kognitif Bozulma. Sel\u00e7uk T\u0131p Derg 28:75\u201379","journal-title":"Sel\u00e7uk T\u0131p Derg"},{"key":"8830_CR24","doi-asserted-by":"publisher","first-page":"12877","DOI":"10.1073\/pnas.1932604100","volume":"100","author":"CJ Willer","year":"2003","unstructured":"Willer CJ, Dyment DA, Risch NJ, Sadovnick AD, Ebers GC (2003) Canadian collaborative Study Group. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A 100:12877\u201312882. https:\/\/doi.org\/10.1073\/pnas.1932604100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8830_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s100720170011","volume":"22","author":"G Rosati","year":"2001","unstructured":"Rosati G (2001) The prevalence of multiple sclerosis in the world: an update. Neurol Sci 22:117\u2013139. https:\/\/doi.org\/10.1007\/s100720170011","journal-title":"Neurol Sci"},{"issue":"1","key":"8830_CR26","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1038\/s41467-019-09773-y","volume":"10","author":"International Multiple Sclerosis Genetics Consortium","year":"2019","unstructured":"International Multiple Sclerosis Genetics Consortium (2019) A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis. Nat Commun 10(1):2236. https:\/\/doi.org\/10.1038\/s41467-019-09773-y","journal-title":"Nat Commun"},{"key":"8830_CR27","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2337\/db07-1331","volume":"57","author":"H Erlich","year":"2008","unstructured":"Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, Mychaleckyj JC, Todd JA, Bonella P, Fear AL, Lavant E, Louey A, Moonsamy P, Type 1 Diabetes Genetics Consortium (2008) HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. J Diabetes 57:1084\u20131092. https:\/\/doi.org\/10.2337\/db07-1331","journal-title":"J Diabetes"},{"key":"8830_CR28","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/ng.3379","volume":"47","author":"TL Lenz","year":"2015","unstructured":"Lenz TL, Deutsch AJ, Han B, Hu X, Okada Y, Eyre S et al (2015) Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases. Nat Genet 47:1085\u20131090. https:\/\/doi.org\/10.1038\/ng.3379","journal-title":"Nat Genet"},{"key":"8830_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms16021","volume":"8","author":"CD Langefeld","year":"2017","unstructured":"Langefeld CD, Ainsworth HC, Graham DS, Kelly JA, Comeau ME, Marion MC et al (2017) Transancestral mapping and genetic load in systemic lupus erythematosus. Nat Commun 8:1\u20138. https:\/\/doi.org\/10.1038\/ncomms16021","journal-title":"Nat Commun"},{"key":"8830_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/ncomms16021","volume":"19","author":"D Dhar","year":"2014","unstructured":"Dhar D, Seki E, Karin M (2014) NCOA5, IL-6, type 2 diabetes, and HCC: the deadly quartet. Cell Metab 19:6\u20137. https:\/\/doi.org\/10.1038\/ncomms16021","journal-title":"Cell Metab"},{"key":"8830_CR31","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.ccr.2013.11.005","volume":"24","author":"S Gao","year":"2013","unstructured":"Gao S, Li A, Liu F, Chen F, Williams M, Zhang C, Kelley Z, Wu CL, Luo R, Xiao H (2013) NCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinoma. Cancer Cell 24:725\u2013737. https:\/\/doi.org\/10.1016\/j.ccr.2013.11.005","journal-title":"Cancer Cell"},{"key":"8830_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fncel.2020.00120","volume":"23","author":"M Stampanoni Bassi","year":"2020","unstructured":"Stampanoni Bassi M, Iezzi E, Drulovic J, Pekmezovic T, Gilio L, Furlan R, Finardi A, Marfia GA, Sica F, Centonze D, Buttari F (2020) IL-6 in the cerebrospinal fluid signals Disease Activity in multiple sclerosis. Front Cell Neurosci 23:120\u2013127. https:\/\/doi.org\/10.3389\/fncel.2020.00120","journal-title":"Front Cell Neurosci"},{"key":"8830_CR33","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/ng.233","volume":"40","author":"S Raychaudhuri","year":"2008","unstructured":"Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, Burtt NP et al (2008) Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 40:1216\u20131223. https:\/\/doi.org\/10.1038\/ng.233","journal-title":"Nat Genet"},{"key":"8830_CR34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.canlet.2017.01.028","volume":"10","author":"X Liu","year":"2017","unstructured":"Liu X, Liu F, Gao S, Reske J, Li A, Wu CL, Yang C, Chen F, Luo R, Xiao H (2017) A single non-synonymous NCOA5 variation in type 2 diabetic patients with hepatocellular carcinoma impairs the function of NCOA5 in cell cycle regulation. Cancer Let 10:152\u2013161. https:\/\/doi.org\/10.1016\/j.canlet.2017.01.028","journal-title":"Cancer Let"},{"key":"8830_CR35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3233\/hab-180341","volume":"26","author":"A Sayad","year":"2018","unstructured":"Sayad A, Salmani T, Hemmesi MK, Ganji M, Ghafouri-Fard S, Hatami M, Soudyab M, Taheri M (2018) Down-regulation of RORA gene expression in the blood of multiple sclerosis patients. Hum Antibodies 26:219\u2013224. https:\/\/doi.org\/10.3233\/hab-180341","journal-title":"Hum Antibodies"},{"key":"8830_CR36","doi-asserted-by":"publisher","unstructured":"3Janssens K, Slaets H, Hellings N (2015) Immunomodulatory properties of the IL-6 cytokine family in multiple sclerosis Ann. N Y Acad Sci 1351:52\u201360. https:\/\/doi.org\/10.1111\/nyas.12821","DOI":"10.1111\/nyas.12821"},{"key":"8830_CR37","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1177\/1352458518763094","volume":"24","author":"K Gobel","year":"2018","unstructured":"Gobel K, Ruck T, Meuth SG (2018) Cytokine signaling in multiple sclerosis: lost in translation. Mult Scler 24:432\u2013439. https:\/\/doi.org\/10.1177\/1352458518763094","journal-title":"Mult Scler"},{"issue":"6","key":"8830_CR38","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1080\/09273948.2021.1889610","volume":"30","author":"DMT Koptan","year":"2022","unstructured":"Koptan DMT, Rasheed Bahgat DM, Abdelrasool AA, Allam RSHM, Elgengehy FT, Abdel Baki NM, Medhat BM (2022) Analysis of nuclear receptor coactivator 5 (NCOA5) Messenger RNA expression and rs2903908 single nucleotide polymorphism of NCOA5 in an egyptian cohort with Beh\u00e7et\u2019s Disease: a single-center case-control study. Ocul Immunol Inflamm 30(6):1436\u20131446","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"8830_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/2040-2392-4-39","volume":"4","author":"T Sarachana","year":"2013","unstructured":"Sarachana T, Hu VW (2013) Differential recruitment of coregulators to the RORA promoter adds another layer of complexity to gene (dys) regulation by sex hormones in autism. Mol Autism 4(1):39. https:\/\/doi.org\/10.1186\/2040-2392-4-39","journal-title":"Mol Autism"},{"key":"8830_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41397-019-0114-0","volume":"20","author":"SA Ayatollahi","year":"2020","unstructured":"Ayatollahi SA, Ghafouri-Fard S, Taheri M, Noroozi R (2020) The efficacy of interferon-beta therapy in multiple sclerosis patients: investigation of the RORA gene as a predictive biomarker. J Pharmacogenomics 20:271\u2013276. https:\/\/doi.org\/10.1038\/s41397-019-0114-0","journal-title":"J Pharmacogenomics"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08830-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-08830-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08830-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T07:37:13Z","timestamp":1699515433000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-08830-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,10]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["8830"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-08830-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2780897\/v1","asserted-by":"object"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,10]]},"assertion":[{"value":"9 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interest. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study was started after the approval of Tokat Gaziosmanpa\u015fa University Faculty of Medicine Ethics Committee (15-KAEK-016).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors confirm that the MS patients and control subjects included in the study gave voluntary consent for the publication of study data and clinical data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}